Red blood cell disorders

H Sidiqi, Wendy Erber

Research output: Chapter in Book/Conference paperChapter

Abstract

Disorders of red blood cells may be due to reduced or excessive production in the bone marrow, premature cell destruction (haemolysis) or loss from the circulation. A precise diagnosis must be made from the blood count, blood film, biochemistry and/or bone marrow examination so that appropriate therapy can be instituted. Anaemia due to a haematinic deficiency can be treated with specific replacement therapy (e.g. iron, vitamin B 12 or folic acid) along with management of the underlying cause. Other secondary anaemias may benefit from haemopoietic growth factor therapy such as erythropoiesis-stimulating agents (e.g. for chronic renal disease), immunosuppression (e.g. for autoimmune haemolytic or aplastic anaemia) or avoidance of specific drugs (e.g. sulfonamides or antibiotics). Inherited disorders of red cells (e.g. haemoglobinopathies) may require specific drug therapy (e.g. hydroxycarbamide for sickle cell disease), folate supplementation and blood transfusion. Over-production of red cells, as in polycythaemia vera, is managed by venesection and, for some patients, suppressing marrow erythropoiesis.
Original languageEnglish
Title of host publicationClinical Pharmacology
EditorsPN Bennett, MJ Brown, P Sharma
Place of PublicationChina
PublisherChurchill Linvingstone
Chapter30
Pages528-542
Edition12
ISBN (Electronic)978-0-7020-7330-4
ISBN (Print)978-0-7020-7328-1, 978-0-7020-7329-8
Publication statusPublished - May 2018

Fingerprint Dive into the research topics of 'Red blood cell disorders'. Together they form a unique fingerprint.

  • Cite this

    Sidiqi, H., & Erber, W. (2018). Red blood cell disorders. In PN. Bennett, MJ. Brown, & P. Sharma (Eds.), Clinical Pharmacology (12 ed., pp. 528-542). Churchill Linvingstone.